(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.33%) $79.21
(0.20%) $2.04
(0.11%) $2 312.10
(0.32%) $26.92
(0.10%) $963.60
(-0.04%) $0.932
(-0.08%) $10.98
(-0.04%) $0.798
(-0.01%) $91.12
Live Chart Being Loaded With Signals
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases...
Stats | |
---|---|
Today's Volume | 1 459.00 |
Average Volume | 8 381.00 |
Market Cap | 2.67M |
EPS | $0 ( 2024-04-01 ) |
Next earnings date | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.100 |
ATR14 | $0.0270 (3.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-24 | Walts Alan Edmund | Buy | 7 500 | Restricted Stock Units |
2024-01-24 | Rubin Steven D | Buy | 7 500 | Restricted Stock Units |
2024-01-24 | Androski Lindsay | Buy | 7 500 | Restricted Stock Units |
2024-01-24 | Aggarwal Sumit | Buy | 60 000 | Restricted Stock Units |
2023-01-30 | Walts Alan Edmund | Buy | 2 859 | Stock Options (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 28 846 630 | Sell: 836 099 |
Eloxx Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
PAIC | 0.954 |
SVAC | 0.941 |
RMRM | 0.917 |
MTSL | 0.873 |
CASI | 0.869 |
TLGT | 0.866 |
AGMH | 0.861 |
BLKB | 0.857 |
SVOK | 0.855 |
KC | 0.851 |
10 Most Negative Correlations | |
---|---|
NETE | -0.961 |
MMAC | -0.934 |
RAVN | -0.907 |
AMRB | -0.891 |
BOCH | -0.89 |
SHSP | -0.867 |
SRAC | -0.837 |
LWAC | -0.819 |
DFFN | -0.806 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eloxx Pharmaceuticals Inc Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-16.65 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-16.65 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1 526.00 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1 378.77 |
Financial Reports:
No articles found.
Eloxx Pharmaceuticals Inc
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators